Get started
Author

George V. Pérez

A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis
1997 · Fred M. Gordin, John P. Matts, et al. · New England Journal of Medicine · 166
PDF
Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?
2010 · Hamid Shaaban, Sunil Daniel, et al. · Journal of Critical Care · 113
Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS
2003 · Ellen M. Tedaldi, Katherine Huppler Hullsiek, et al. · Clinical Infectious Diseases · 68
Status of selected nutrients and progression of human immunodeficiency virus type 1 infection
2000 · John D Bogden, Francis W Kemp, et al. · American Journal of Clinical Nutrition · 66
Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: Report from the heterosexual hiv transmission study
1998 · George Perez, Joan H. Skurnick, et al. · International Journal of Infectious Diseases · 61
Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial
1994 · M. A. Jacobson, C. L. Besch, et al. · The Journal of Infectious Diseases · 56
Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials
2008 · Alan R. Lifson, Waldo H. Belloso, et al. · HIV Clinical Trials · 52
PDF
Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials
2010 · Alan R. Lifson, Waldo H. Belloso, et al. · HIV Clinical Trials · 44
PDF
Behavioral and Demographic Risk Factors for Transmission of Human Immunodeficiency Virus Type 1 in Heterosexual Couples: Report from the Heterosexual HIV Transmission Study
1998 · Joan H. Skurnick, Cheryl A. Kennedy, et al. · Clinical Infectious Diseases · 43
PDF
Angioneurotic edema, agranulocytosis, and fatal septicemia following captopril therapy
1986 · Manuel Suarez, Peter Wan Lye Ho, et al. · The American Journal of Medicine · 40
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
2020 · Leticia R. Cruz, Idania Baladrón, et al. · ACS Pharmacology & Translational Science · 39
PDF
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
2016 · Helen Kovari, Caroline A. Sabin, et al. · Open Forum Infectious Diseases · 30
PDF
Impact of adding maraviroc to antiretroviral regimens in patients with full viral suppression but impaired CD4 recovery
2009 · Olena Stepanyuk, Tom S Chiang, et al. · AIDS · 28
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
2021 · Mauro Rosales, George V. Pérez, et al. · Biomedicines · 25
PDF
Kodamaea Ohmeri Fungemia in an Immunocompetent Patient Treated with Micafungin: Case Report and Review of the Literature
2010 · Hamid Shaaban, Hoo Feng Choo, et al. · Mycopathologia · 25
Viral Load and CD4+ Cell Count as Risk Factors for Prolonged QT Interval in HIV-Infected Subjects: A Cohort-Nested Case-Control Study in an Outpatient Population
2010 · Ashraf Y. QaQa, Hamid Shaaban, et al. · Cardiology · 25
Comparison of Prognostic Importance of Latest CD4+ Cell Count and HIV RNA Levels in Patients with Advanced HIV Infection on Highly Active Antiretroviral Therapy
2005 · Rodger D. MacArthur, George Perez, et al. · HIV Clinical Trials · 22
PDF
A Randomized Study of the Safety and Antiretroviral Activity of Hydroxyurea Combined with Didanosine in Persons Infected with Human Immunodeficiency Virus Type 1
2000 · James A. Hellinger, Marika K. Iwane, et al. · The Journal of Infectious Diseases · 21
CD4+Cell Count Increase Predicts Clinical Benefits in Patients with Advanced HIV Disease and Persistent Viremia after 1 Year of Combination Antiretroviral Therapy
2005 · Mona R. Loutfy, Sharon L. Walmsley, et al. · The Journal of Infectious Diseases · 19
PDF
Rates of Tuberculosis Infection in Healthcare Workers Providing Services to HIV-Infected Populations
1998 · Karen Zahnow, John P. Matts, et al. · Infection Control and Hospital Epidemiology · 14
Lymphocyte shedding from genital tract of human immunodeficiency virus–infected women: Immunophenotypic and clinical correlates
1997 · Arlene D. Bardeguez, Joan H. Skurnick, et al. · American Journal of Obstetrics and Gynecology · 14
The Role of Postexercise Measurements in the Diagnosis of Peripheral Arterial Disease in HIV-Infected Patients
2010 · Ashraf Y. Qaqa, Vincent A. DeBari, et al. · Angiology · 13
Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1
2005 · Stephen M Smith, Michael J Donio, et al. · Retrovirology · 11
PDF
Rates of Tuberculosis Infection in Healthcare Workers Providing Services to HIV-Infected Populations
1998 · Karen Zahnow, John P. Matts, et al. · Infection Control and Hospital Epidemiology · 11
CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: A report from the heterosexual HIV transmission study
1998 · Thomas N. Denny, Joan H. Skurnick, et al. · International Journal of Infectious Diseases · 11
PDF
Works count: 39
Citation count: 1,063
H-index: 19
I10-index: 27
Year
Topic
Type